Related Experiment Video

Updated: Mar 15, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.4K

Association between ACR1 gene product expression and cardiomyopathy in children

Yan Wang1, Ling Niu1, Xiuhua He1

  • 1Department of Cardiology, Xuzhou Children's Hospital, Xuzhou, Jiangsu 221002, P.R. China.

Experimental and Therapeutic Medicine
|September 3, 2016
PubMed

Insights

Pediatric cardiomyopathy involves increased morbidity, but effective treatments remain elusive. This study found reduced ACR1 gene product levels in children with cardiomyopathy, suggesting a link between ACR1 inhibition and disease development.

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Pediatric cardiomyopathy is a serious condition with increasing morbidity and limited effective treatments.
  • Understanding the molecular mechanisms underlying pediatric cardiomyopathy is crucial for developing new therapeutic strategies.

Purpose of the Study:

  • To investigate the expression of ACR1 gene products in children diagnosed with cardiomyopathy.
  • To determine the association between ACR1 expression levels and the pathogenesis of pediatric cardiomyopathy.

Main Methods:

  • Quantified ACR1 mRNA and protein levels using RT-qPCR, ELISA, and Western blot analysis in 73 pediatric cardiomyopathy patients and 76 healthy controls.
  • Utilized immunohistochemistry to examine ACR1 expression in cardiac tissue samples.
  • Collected samples between April 2013 and April 2015.

Main Results:

  • No significant difference in ACR1 mRNA levels was observed between patients and controls via RT-qPCR.
  • ELISA and Western blot analysis revealed significantly lower ACR1 protein levels in pediatric cardiomyopathy patients.
  • Immunohistochemistry indicated a progressive decrease in ACR1 levels correlating with disease progression in patients.

Conclusions:

  • Inhibition of ACR1 gene expression is associated with the development and progression of pediatric cardiomyopathy.
  • Reduced ACR1 levels represent a potential biomarker and therapeutic target for pediatric cardiomyopathy.
  • Further research into ACR1's role can elucidate cardiomyopathy pathogenesis and inform treatment development.

Keywords:
ACR1 geneRT-PCRcardiomyopathy of childrencorrelationtreatment

More Related Videos

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish08:09

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

Published on: June 7, 2018

10.4K
Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients09:16

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients

Published on: February 28, 2018

8.1K

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
726
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
618
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
742
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
749
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
716